Michael Ciesielski, PhD of Roswell Park Cancer Institute discusses the treatment trends in 2017 for his field, neuro-oncology, which include more use of checkpoint inhibitors and combination therapies. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Treatment Trends 2017 for Neuro-Oncology include Checkpoint Inhibitors and Combination Therapy
